Why Is Novartis Stock Trading Higher On Thursday?

Thursday, Novartis AG NVS shares are trading higher after the company confirmed plans to file for Pluvicto pre-taxane label expansion in the second half of 2024 based on data from its Phase 3 PSMAfore study. Updated overall survival (OS) results from a pre-planned analysis at approximately 75%…#novartisag #phase3psmafore #itt #radiographic #readnovartisagrees #cancerdrugdeveloper #mcrpc #nvs
Source: Reuters: Health - Category: Consumer Health News Source Type: news